2nd Quarter - Report

QUADRIPOINT STRATEGIES LLC for AMBIO

Period 2nd Quarter 2019 Filed Jul 22, 2019 Signed by David Crane

Official filing
Firm
QUADRIPOINT STRATEGIES LLC
Client
AMBIO
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

FDA regulation of generic insulin and peptide-based insulin products

LobbyistCovered position, as disclosed
DAVID CRANE Senior Policy Advisor, Majority Leader/Republican Leader Trent Lott, Professional Staff, Senate Commerce Committee, Chairman John McCain, LA/LD Senator Dan Coats

Contacted: Food & Drug Administration (FDA); Office of the Vice President of the United States; SENATE; White House Office; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.